BioServUK Ltd

AltaBioscience is recognised worldwide as a leading manufacturing and analysis laboratory providing synthesis of DNA and peptides and analysis of proteins and other biochemical molecules, to researchers in academia, pharmaceuticals and the food industry.

Certified to ISO/IEC 17025:2005 for amino acid analysis, protein sequencing and steroid analysis. ISO 9001:2008 for the laboratory as a whole, AltaBioscience is committed to supplying high-quality products and analytical services at competitive prices.

• Custom Peptide Synthesis
• Tags & Conjugations
• Amino Acid Analysis
• N-Terminal Edman Protein Sequencing
• DNA/Oligo Synthesis
• Custom Antibody Generation
• Circular Dichroism analysis
• HPLC and MS Analytical Testing

The Antibody Company was founded in response to a need for a high quality contract manufacturing service that is fast, flexible and reliable. The Antibody Company brings 20 years of expertise in the production, purification, downstream processing and conjugation of antibodies.

Using class-leading technology we are able to produce antibodies at 10-100 times the concentration of conventional techniques, saving on reagent costs and easing downstream processing.

The technology we use allows for rapid production of monoclonal antibodies at higher concentrations than conventional techniques. This reduces the costs of reagents, processing and labour. In addition downstream processing is streamlined, allowing for a higher quality end product.

We recognise that each project will be unique and with 20 years of experience of monoclonal antibody production and purification, we can customize each project to the clients’ needs.

In addition, The Antibody Company provides a cell banking and cryostorage service.

30 years of experience in IVD..

DIAsource ImmunoAssays (formerly BioSource) an international diagnostics company (Belgium), develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. Core products are RIA and ELISA technology and reagents for open ELISA automated analyzers as well as antibodies for use in in-vitro diagnostic assays with specific development and manufacturing programs for Vitamin D, Renin, Calcitonin and many others. We also provide selected instrumentation for ELISA . It is our ambition to use our 30 years of expertise in Antibody and Assay development to become a well-known source of diagnostic immunoassays for the IVD market.

The mission of GERBU Biotechnik GmbH is to ensure reliable supply of Biochemicals at the most affordable prices and exceptional quality. Our prime focus is to diversify global trade through impeccable networking , responsible approach, observance of sustainability and thus creating a notable presence worldwide.

GERBU Biotechnik GmbH was founded in 1986 by Nikolaus Grubhofer, starting with a small range of common Biochemicals and systematically expanding its capacity for production and trade.

For more than 30 years GERBU has developed itself in establishing raw material sourcing, manufacturing and active trading with our long-term partners and trusted customers. We are committed in providing our valuable customers and partners outstanding service with principle approach of careful selection, prioritization and credibility assurance.

Our key product range includes Biochemicals, Reagents, Immunoadjuvants for antibody production, Immunomodulators, Buffers and other unique and sophisticated products designed by our partners to make your research a success.

GERBU Biotechnik GmbH is ISO 9001: 2015 Certified

Immunitrack provides a product and service pipeline to optimize immunogenicity assessments during drug development, as well as a broad portfolio of reagents to monitor patient CD8 and CD4 T cell responses to lead drug candidates during early R&D and clinical trials.

How Can Immunitrack Help R&D?
The Major Histocompatibility Complex (MHC) is critical to the immune response. Immunitrack has world-leading expertise in the manufacture and application of MHC I and II molecules to accurately study MHC epitope binding through our proprietary NeoScreen® platform.

Major Areas of Application
• Immuno-oncology: selection and study of neo-epitopes for personalized cancer vaccine development
• Vaccine development: selection of immunogenic epitopes from viral and bacterial targets
• Reducing immunogenicity of biologics: reduce the risk of anti-drug antibody development by identifying and removing CD4 T cell epitopes in candidate biologics.

Reagents
We produce customized MHC tetramers to detect and quantify subsets of patient immune (T) cells with specificity towards a given antigen within blood samples.

All of our MHC I reagents are produced on our optimized manufacturing platform, and we guarantee 100% peptide loading of each complex.

Binding Assays
Our unique NeoScreen® platform combines more than a decade of world-leading expertise in MHC/epitope binding assays with a high level of automation. The result is a highly scalable and accurate platform that can screen thousands of (neo-)epitopes.

Depending on the desired immune response our clients can then select and progress the best candidates through therapeutic development. Our repository is continuously growing, and currently holds more than 70 different MHC I and 20 MHC II alleles.